Trigger Point Treatment in Chronic Pelvic Pain
CompletedNot applicableNCT05546203
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Objective: To investigate the effectiveness of ischemic compression and low-level laser therapy methods combined with exercise on the myofascial trigger points in women with Chronic Pelvic Pain and to determine which method is more effective. Methods: It was a parallel designed, single-blind pilot randomized clinical trial. Patients were enrolled in the Department of Obstetrics and Gynecology (at Istanbul University-Cerrahpasa). The patients were diagnosed by a gynecologist (F.G.U and C. Y.), referred to the clinical laboratory of physiotherapy and rehabilitation to participate (by physiotherapists K.S. and E.K.M.) in the trial from September 2017 to June 2019. Twenty-eight women patients with Chronic Pelvic Pain were included into the trial. Patients were randomized into two groups. Group 1 received ischemic compression and Group 2 received low-level laser therapy twice a week for 6 weeks. Both groups received the same standard exercise program. Pain, range of motion, pelvic floor symptom severity, quality of life, satisfaction, anxiety, and depression were assessed after 6 weeks and 1-year follow up.
Study details
- Official title
- The Effectiveness of Trigger Point Treatment in Chronic Pelvic Pain; A Pilot Randomized Controlled Trail
- Conditions
- Chronic Pelvic Pain Syndrome
- Myofascial Trigger Point Pain
- Interventions
- Other: Ischemic compression
- Device: Low-level laser therapy
- Behavioral: Standardized exercise program
- Sponsor
- Munzur University
- Collaborators
- Istanbul University - Cerrahpasa
- Start date
- 2017-09-01
- Primary completion
- 2018-06-01
- Sex
- Female
- Age range
- from 18 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria:To be eligible, * participants had to be between 18-50 years of age, * had pain/discomfort in the lower abdominal and pelvic region lasting for 3 months in the last 6 months. * Patients with MTrPs in at least two of the examined muscles (rectus abdominis, piriformis, quadratus lumborum, gluteus maximus-medius, adductor magnus, hamstring) were included in order to perform statistical analysis. Exclusion Criteria: The exclusion criteria were; * anticoagulation or bleeding disorders, * neuropathy, central nervous system disorders, * advanced psychiatric disorders, * significant pelvic pathology or abnormality, severe prolapse, pregnancy, * to have undergone major surgery and pelvic surgery with general anesthesia in the last 3 months, * to have received treatment including electrotherapy and manual therapy for the pelvic region in the last 6 months.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05546203